questionsmedicales.fr
Bactéries
Proteobacteria
Gammaproteobacteria
Vibrionaceae
Vibrionaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vibrionaceae : Questions médicales les plus fréquentes",
"headline": "Vibrionaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vibrionaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-17",
"dateModified": "2025-03-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vibrionaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Gammaproteobacteria",
"url": "https://questionsmedicales.fr/mesh/D020563",
"about": {
"@type": "MedicalCondition",
"name": "Gammaproteobacteria",
"code": {
"@type": "MedicalCode",
"code": "D020563",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aliivibrio",
"alternateName": "Aliivibrio",
"url": "https://questionsmedicales.fr/mesh/D059706",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio",
"code": {
"@type": "MedicalCode",
"code": "D059706",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aliivibrio fischeri",
"alternateName": "Aliivibrio fischeri",
"url": "https://questionsmedicales.fr/mesh/D048908",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio fischeri",
"code": {
"@type": "MedicalCode",
"code": "D048908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050.860"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aliivibrio salmonicida",
"alternateName": "Aliivibrio salmonicida",
"url": "https://questionsmedicales.fr/mesh/D044165",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio salmonicida",
"code": {
"@type": "MedicalCode",
"code": "D044165",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050.930"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Listonella",
"alternateName": "Listonella",
"url": "https://questionsmedicales.fr/mesh/D053526",
"about": {
"@type": "MedicalCondition",
"name": "Listonella",
"code": {
"@type": "MedicalCode",
"code": "D053526",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Photobacterium",
"alternateName": "Photobacterium",
"url": "https://questionsmedicales.fr/mesh/D010776",
"about": {
"@type": "MedicalCondition",
"name": "Photobacterium",
"code": {
"@type": "MedicalCode",
"code": "D010776",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio",
"alternateName": "Vibrio",
"url": "https://questionsmedicales.fr/mesh/D014733",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio",
"code": {
"@type": "MedicalCode",
"code": "D014733",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio alginolyticus",
"alternateName": "Vibrio alginolyticus",
"url": "https://questionsmedicales.fr/mesh/D044149",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio alginolyticus",
"code": {
"@type": "MedicalCode",
"code": "D044149",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.030"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae",
"alternateName": "Vibrio cholerae",
"url": "https://questionsmedicales.fr/mesh/D014734",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae",
"code": {
"@type": "MedicalCode",
"code": "D014734",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio mimicus",
"alternateName": "Vibrio mimicus",
"url": "https://questionsmedicales.fr/mesh/D044164",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio mimicus",
"code": {
"@type": "MedicalCode",
"code": "D044164",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio parahaemolyticus",
"alternateName": "Vibrio parahaemolyticus",
"url": "https://questionsmedicales.fr/mesh/D014736",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio parahaemolyticus",
"code": {
"@type": "MedicalCode",
"code": "D014736",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio vulnificus",
"alternateName": "Vibrio vulnificus",
"url": "https://questionsmedicales.fr/mesh/D041261",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio vulnificus",
"code": {
"@type": "MedicalCode",
"code": "D041261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.900"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vibrionaceae",
"alternateName": "Vibrionaceae",
"code": {
"@type": "MedicalCode",
"code": "D014737",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Chunqi Jiang",
"url": "https://questionsmedicales.fr/author/Chunqi%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan."
}
},
{
"@type": "Person",
"name": "Sayaka Mino",
"url": "https://questionsmedicales.fr/author/Sayaka%20Mino",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan."
}
},
{
"@type": "Person",
"name": "Jesús L Romalde",
"url": "https://questionsmedicales.fr/author/Jes%C3%BAs%20L%20Romalde",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Microbiología y Parasitología, CRETUS & CIBUS-Facultad de Biología, Universidade de Santiago de Compostela, Campus Vida, Santiago de Compostela, España."
}
},
{
"@type": "Person",
"name": "Tomoo Sawabe",
"url": "https://questionsmedicales.fr/author/Tomoo%20Sawabe",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan. sawabe@fish.hokudai.ac.jp."
}
},
{
"@type": "Person",
"name": "William Soto",
"url": "https://questionsmedicales.fr/author/William%20Soto",
"affiliation": {
"@type": "Organization",
"name": "Integrated Science Center Rm 3035, Department of Biology, College of William & Mary, 540 Landrum Dr., Williamsburg, VA 23185, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Information disclosure to cancer patients in Mainland China: A meta-analysis.",
"datePublished": "2023-01-05",
"url": "https://questionsmedicales.fr/article/36582008",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pon.6085"
}
},
{
"@type": "ScholarlyArticle",
"name": "Error disclosure in neonatal intensive care: a multicentre, prospective, observational study.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36918264",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjqs-2022-015247"
}
},
{
"@type": "ScholarlyArticle",
"name": "HIV status disclosure and sexual activity among pregnant women in Ghana.",
"datePublished": "2022-09-14",
"url": "https://questionsmedicales.fr/article/36102039",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09540121.2022.2121375"
}
},
{
"@type": "ScholarlyArticle",
"name": "Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer.",
"datePublished": "2024-06-10",
"url": "https://questionsmedicales.fr/article/38856947",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00520-024-08630-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "\"Seed Planting\" As an Approach for Longitudinal Prognostic Disclosure in Pediatric Cancer: A Case Series.",
"datePublished": "2022-09-12",
"url": "https://questionsmedicales.fr/article/36094817",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1089/jpm.2022.0219"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gammaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020563"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vibrionaceae",
"item": "https://questionsmedicales.fr/mesh/D014737"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vibrionaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vibrionaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vibrionaceae",
"description": "Comment diagnostiquer une infection par Vibrionaceae ?\nQuels tests sont utilisés pour identifier Vibrio cholerae ?\nLes tests sérologiques sont-ils utiles pour Vibrionaceae ?\nQuels symptômes indiquent une infection vibrionique ?\nComment différencier Vibrionaceae d'autres bactéries ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Truth+Disclosure&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vibrionaceae",
"description": "Quels sont les symptômes courants d'une infection par Vibrionaceae ?\nLes infections vibrioniques causent-elles des vomissements ?\nY a-t-il des symptômes graves associés aux Vibrionaceae ?\nLes symptômes apparaissent-ils rapidement après infection ?\nLes infections vibrioniques peuvent-elles être asymptomatiques ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Truth+Disclosure&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vibrionaceae",
"description": "Comment prévenir les infections par Vibrionaceae ?\nLes vaccins existent-ils contre Vibrionaceae ?\nQuelles mesures de sécurité alimentaire sont recommandées ?\nLes voyageurs doivent-ils prendre des précautions ?\nL'hygiène des mains est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Truth+Disclosure&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vibrionaceae",
"description": "Quel est le traitement principal pour les infections par Vibrionaceae ?\nLes antibiotiques sont-ils nécessaires pour traiter Vibrionaceae ?\nComment prévenir la déshydratation dans les infections vibrioniques ?\nLes traitements symptomatiques sont-ils efficaces ?\nY a-t-il des traitements spécifiques pour le choléra ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Truth+Disclosure&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vibrionaceae",
"description": "Quelles complications peuvent survenir avec Vibrionaceae ?\nLe choléra peut-il entraîner des complications graves ?\nLes infections vibrioniques peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?\nLes personnes âgées sont-elles plus à risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Truth+Disclosure&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vibrionaceae",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes immunodéprimées sont-elles à risque ?\nLe climat influence-t-il le risque d'infection ?\nLes enfants sont-ils plus vulnérables ?\nLes voyages dans certaines régions augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Truth+Disclosure&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Vibrionaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture bactérienne à partir d'échantillons de selles."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Vibrio cholerae ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des méthodes moléculaires comme la PCR sont utilisés."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques sont-ils utiles pour Vibrionaceae ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne sont généralement pas utilisés pour le diagnostic des infections vibrioniques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection vibrionique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la diarrhée, les vomissements et la déshydratation peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment différencier Vibrionaceae d'autres bactéries ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse des caractéristiques morphologiques et des tests biochimiques aide à la différenciation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection par Vibrionaceae ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée aqueuse, crampes abdominales et fièvre."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques causent-elles des vomissements ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vomissements sont fréquents, surtout dans les cas de choléra."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes graves associés aux Vibrionaceae ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves incluent la déshydratation sévère et le choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement après infection ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent apparaître rapidement, souvent dans les 24 heures."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques peuvent-elles être asymptomatiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent être asymptomatiques, surtout chez les porteurs sains."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Vibrionaceae ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne hygiène, la cuisson des aliments et l'eau potable."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils contre Vibrionaceae ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un vaccin contre le choléra est disponible, mais pas pour toutes les espèces de Vibrionaceae."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité alimentaire sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de bien cuire les fruits de mer et de ne pas consommer d'eau non traitée."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils prendre des précautions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs vers des zones à risque doivent être prudents avec l'eau et la nourriture."
}
},
{
"@type": "Question",
"name": "L'hygiène des mains est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, se laver les mains régulièrement est crucial pour prévenir les infections."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les infections par Vibrionaceae ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhydratation orale ou intraveineuse est le traitement principal, surtout pour le choléra."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires pour traiter Vibrionaceae ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques peuvent être prescrits dans les cas graves, mais ne sont pas toujours nécessaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déshydratation dans les infections vibrioniques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'administration rapide de solutions de réhydratation est essentielle pour prévenir la déshydratation."
}
},
{
"@type": "Question",
"name": "Les traitements symptomatiques sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements symptomatiques comme les antiémétiques peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements spécifiques pour le choléra ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques spécifiques et des solutions de réhydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec Vibrionaceae ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent la déshydratation sévère, le choc et l'insuffisance rénale."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il entraîner des complications graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choléra peut entraîner des complications graves comme le choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques peuvent-elles être mortelles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement approprié, les infections peuvent être mortelles, surtout chez les vulnérables."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par une réhydratation rapide et un traitement médical approprié."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent la consommation de fruits de mer crus et l'eau contaminée."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées courent un risque accru d'infections graves."
}
},
{
"@type": "Question",
"name": "Le climat influence-t-il le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections par Vibrionaceae sont plus fréquentes dans les climats chauds et humides."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables aux infections et à leurs complications."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines régions augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions à risque augmente la probabilité d'infection par Vibrionaceae."
}
}
]
}
]
}
This study aims to systematically examine Chinese cancer patients' and families' preferences for information disclosure to the patient, patient awareness, and predictors of patient awareness....
The Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines were followed. Web of Science, Scopus, Proquest, Taylor & Francis Online, and China National Knowledge Infrastructure ...
A total of 22 studies were included, and the average quality score was 0.65/1. Meta-analyses showed that 89.6% and 81.8% of cancer patients wanted to know their diagnosis and prognosis, respectively. ...
Chinese cancer patients are eager to know their diagnosis and prognosis, but families are hesitant about disclosure to the patient, and patients' awareness is low. While cultural, legal, and medical b...
Surveys based on hypothetical situations suggest that health-care providers agree that disclosure of errors and adverse events to patients and families is a professional obligation but do not always d...
To measure the proportion of errors disclosed by neonatal intensive care unit (NICU) professionals to parents and identify motives for and barriers to disclosure....
Prospective, observational study nested in a randomised controlled trial (Study on Preventing Adverse Events in Neonates (SEPREVEN); ClinicalTrials.gov). Event disclosure was not intended to be relate...
10 NICUs in France with a 20-month follow-up, starting November 2015....
n=1019 patients with NICU stay ≥2 days with ≥1 error....
Characteristics of errors (type, severity, timing of discovery), patients and professionals, self-reported motives for disclosure and non-disclosure....
Rate of error disclosure reported anonymously and voluntarily by physicians and nurses; perceived parental reaction to disclosure....
Among 1822 errors concerning 1019 patients (mean gestational age: 30.8±4.5 weeks), 752 (41.3%) were disclosed. Independent risk factors for non-disclosure were nighttime discovery of error (OR 2.40; 9...
In the particular context of the SEPREVEN randomised controlled trial of NICUs, staff did not disclose the majority of errors to parents, especially in the absence of moderate consequence for the infa...
NCT02598609....
Human Human immunodeficiency virus (HIV) status disclosure to sexual partners is associated with prevention, care, treatment, and support for pregnant women with HIV. We aimed to assess HIV status dis...
Determining whether patients' unrealistic expectations of chemotherapy as a cure were associated with their perception of the disclosure of incurability....
This prospective study included consecutive patients with pretreated non-small cell lung cancer from four study sites. Patients and their oncologists were asked whether they perceived the disclosure o...
We analyzed 200 patients, 77 (38.5%) of whom had unrealistic expectations of a cure. Based on patients' perceptions, incurability was disclosed to 138 (69.0%) patients, and based on their oncologists'...
Oncologists' disclosure of incurability was not fully recognized by patients, and expectations of chemotherapy as a cure were associated with patients' perception of the disclosure of incurability....
Most children with cancer and their parents desire honest communication about prognosis, even when prognosis is poor. Unfortunately, many parents perceive deficits in communication about prognosis, an...
Disclosure of medical errors, in which a health care provider informs the patient/family of the error and takes responsibility, is an ethical imperative. Little is known about how medical error disclo...
The researchers conducted a narrative review on medical errors and disclosure. Included were studies in high-income countries that included a predominantly marginalized population, defined by any one ...
The literature search yielded 3,050 articles, resulting in 6 studies included for analysis. Four studies used hypothetical vignettes; 1 used focus groups, and 1 used a survey. Three studies met the ma...
Participants from marginalized populations may have similar disclosure preferences to white and highly educated participants. Future studies should aim to examine differences in error disclosure prefe...
Although the disclosure of medical errors is an integral component of medical ethics, it remains inconsistent in practice worldwide. Despite various explanations of why healthcare professionals reveal...
This work will focus on studies involving medical professionals from various countries who work in hospital settings and have obtained an understanding of and firsthand experience with medical error d...
Ethical approval is not required for the study because the review will be based on pre-existing data available in the literature. The results of this systematic review will be submitted to peer-review...
CRD42024494360....
Parents whom adolescents disclose sexual abuse face both a personal traumatic experience, and the need to support their child who is going through a grueling period and needs them. Many quantitative s...
We conducted semi structured interviews with parents whose children disclosed sexual abuse during their psychiatric care in Paris and analyzed these interviews using a phenomenological framework (inte...
This study analyzed 13 semi structured interviews of 9 mothers and 4 fathers whose children were then aged 14 to 17 years. Qualitative analysis uncovered three themes: (1) Parents: alerts and search f...
Considering the parental experience is essential in caring for adolescent patients after they disclose sexual abuse. The need for parental or family psychological support should be systematically asse...
For children with advanced cancer and their families, communication about prognosis is critical. Unfortunately, data demonstrate that prognostic communication occurs infrequently and inconsistently ac...
Children with poor-prognosis solid tumors, their parents, and oncologists were followed prospectively for 24 months or until death. Matched semi-structured interviews were conducted with parents and o...
A total of 68 interviews were conducted following serial disease reevaluation encounters involving 13 parents and five oncologists. Nine main themes were identified as "best" approaches: (1) speaking ...
Parents and oncologists described clear recommendations for helpful communication strategies and pitfalls to avoid during difficult prognostic disclosure. Future work should integrate patient perspect...
in Africa, the proportion of minors with AIDS is ever increasing and adherence to treatment protocols is still suboptimal. The study investigated the conditions of HIV status disclosure and adherence ...
in 2016, thirteen health professionals and four parents filled out questionnaires to identify problems and solutions relative to disclosure of HIV status and adherence to treatment in 208 children and...
medians (extrema) of patients´ ages at start and end of status disclosure process were 10 (8-13) and 15 (13-17.5) years. In 61% of cases, disclosure was made individually after preparation sessions. T...
despite persisting disclosure and adherence problems, appropriate measures already put into practice still need to be taken further, especially through engaging psychologists, training counsellors, an...